Mkts

Prime Medicine, Inc.

NASDAQ: PRME
$3.82-0.02 (-0.52%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
3.764.28
52-week range
2.675.91
Today
Open3.81
Previous close3.82
Volume323.9K
Valuation
Market cap694.94M
P/E ratio—
EPS (TTM)-1.09
Income & risk
Dividend / yield—
Beta2.19
Avg volume4.04M
Discussion

PRME News

Stories mentioning PRME from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue838.001,2251,1151,4542,183209.000.00
Cost of Goods Sold
Gross Profit0.00
Operating Expenses
Research & Development34,10534,70943,99041,37540,56234,10440,34043,071
Sales General & Admin
Total Operating Expenses51,51049,44655,19854,49253,84646,40554,44155,672
Operating Income (Loss)(50,654)(48,608)(53,973)(53,377)(52,392)(44,222)(54,232)(55,672)
Interest Income1,0211,0831,141743.001,1821,538697.00611.00
Interest Expense
Other Expense51.0049.0044.0018.0037.0043.00(83.00)39.00
Pretax Income
Tax Provision0.000.000.000.00(134.00)
Net Income (Loss)(49,122)(46,079)(50,582)(52,591)(51,890)(42,276)(52,518)(55,327)
Earnings Per Share (Basic)(0.28)(0.31)(0.32)(0.41)(0.40)(0.36)(0.44)(0.46)
Earnings Per Share (Diluted)(0.28)(0.31)(0.32)(0.41)(0.40)(0.36)(0.44)(0.46)
Weighted Average Shares Outstanding (Basic)177,096148,759160,503129,186130,884118,600119,764119,189
Weighted Average Shares Outstanding (Diluted)177,096148,759160,503129,186130,884118,600119,764119,189

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PRME

Prime Medicine, Inc. (NASDAQ: PRME) is a stock listed on the Nasdaq Stock Market under the ticker symbol PRME. It last traded at $3.82 (Nov 18, 2026, 4:00 PM ET), down 0.5% on the day. That gives Prime Medicine a market capitalisation of $694.9M.

Over the past 52 weeks PRME has traded between $2.67 and $5.91.

For the quarter ended Mar 31, 2026 it reported a net loss of $49.1M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026—-$49.1M—
Dec 31, 2025$838.0K-$46.1M-5498.7%
Sep 30, 2025$1.2M-$50.6M-4129.1%
Jun 30, 2025$1.1M-$52.6M-4716.7%

From Prime Medicine’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…